Precision Psychiatry Market Size, Share, Trends, Industry Analysis Report By Product Type, By Sample, By Biomarker Type, By Technology, By Application, By End User, and By Region – Market Forecast, 2025–2034

The precision psychiatry market size is expected to reach USD 3,254.83 Million by 2034, according to a new study by Polaris Market Research. The report “Precision Psychiatry Market Share, Size, Trends, Industry Analysis Report: By Product Type, By Sample, By Biomarker Type, By Technology, By Application, By End User, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global precision psychiatry market includes tools and technologies for identifying biomarkers and genetic patterns linked to psychiatric disorders, enabling targeted diagnosis and personalized treatment across pharmaceutical and clinical research settings.

Market growth is driven by rising mental health awareness, expanding neurogenomic research, and increasing adoption of AI-based diagnostic tools that enhance treatment precision and clinical outcomes.

Precision Psychiatry Market Report Highlights
Based on product type, the products segment dominated in 2024 due to increasing use of genomic and biomarker testing tools in clinical and research applications.
In terms of sample, the blood-based segment held the largest share in 2024 supported by its reliability and non-invasive nature in biomarker detection.
Based on biomarker type, the genetic biomarker segment dominated in 2024 driven by rising research on psychiatric gene variants and heritable risk factors.
In terms of technology, the sequencing segment dominated in 2024 due to growing adoption of next-generation sequencing in neurogenomic analysis.
Based on application, the depression segment is projected to grow fastest, driven by expanding genomic research and AI-based diagnostics.
In terms of end user, the hospitals and diagnostic laboratories dominated in 2024, due to high patient volume and growing genomic testing adoption.
North America dominated the market in 2024 due to strong mental health research infrastructure and advanced AI-enabled diagnostics.
Asia Pacific is projected to grow fastest from 2025 to 2034, driven by rising genomic research funding and growing mental health awareness.
Key players in the global market include Boehringer Ingelheim International GmbH, Alto Neuroscience Inc., Altimate Healthcare, Feel Therapeutics, Tempus, HMNC Holding GmbH, Spring Care, Inc., Mobio Interactive, NeuroKaire, Illumina, Inc., Otsuka Precision Health, Inc., Genomind, and Atai Life Sciences N.V.
Request a free sample copy or read the full market insights : precision psychiatry market Report

Polaris Market Research has segmented the market report based on product type, sample, biomarker type, technology, application, end user, and region:
By Product Type Outlook (Revenue, USD Million, 2020–2034)

Products
Services
By Sample Outlook (Revenue, USD Million, 2020–2034)

Blood-Based
Non-Blood-Based
Saliva
Urine
Cerebral Spinal Fluid (CSF)
Others
By Biomarker Type Outlook (Revenue, USD Million, 2020–2034)

Genetic Biomarker
Protein Biomarker
By Technology Outlook (Revenue, USD Million, 2020–2034)

Sequencing
Next-Generation Sequencing (NGS)
Sanger Sequencing
Polymerase Chain Reaction (PCR)
Real-Time Polymerase Chain Reaction (RT-PCR)
Digital Polymerase Chain Reaction (dPCR)
Microarray
Immunoassay
Liquid Chromatography-Mass Spectrometry (LC-MS)
Others
By Application Outlook (Revenue, USD Million, 2020–2034)

Alzheimer’s Disease
Parkinson’s Disease
Autism
Depression
Bipolar Disease
Others
By End User Outlook (Revenue, USD Million, 2020–2034)

Hospitals and Diagnostic Laboratories
Academic and Research Institutions
Others
By Regional Outlook (Revenue, USD Million, 2020–2034)

North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America Show more